释放生物仿制药潜力:眼科案例研究
IQVIAIQVIA(US:IQV)2026-02-25 01:20

Unlocking Biosimilar Potential Ophthalmology Case Study FEBRUARY 2026 Introduction Ensuring that challenges to biosimilar uptake are continuously assessed and addressed is a critical part of unlocking their benefits. Biosimilar use is growing across therapy areas with different specialties gaining experience and confidence. These biosimilars have also provided substantial savings for the overall health system. Between 2023 and 2025, IQVIA Institute has published two reports highlighting the importance of ph ...